Skip to main content
. 2013 Aug 1;98(8):E1414–E1421. doi: 10.1210/jc.2013-1408

Figure 2.

Figure 2.

A–E, Whole section of anaplastic carcinoma with associated PTC tall cell variant (PTC TCV). Both the PTC TCV and anaplastic components have BRAF V600E mutation. A, Low-power view with diffuse homogeneous 3+ immunostaining for VE1 in PTC TCV (top arrow) and anaplastic (bottom arrow) components. B, High-power view of the PTC TCV component showing 3+ VE1 immunostaining. D, Corresponding H&E staining for B. C, High-power view of anaplastic component showing 3+ VE1 immunostaining. E, Corresponding H&E staining for C.